BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23016424)

  • 21. [Current status of non-viral vectors for siRNA delivery].
    Yang FF; Huang W; Li YF; Gao ZG
    Yao Xue Xue Bao; 2011 Dec; 46(12):1436-43. PubMed ID: 22375415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing.
    Bartlett DW; Davis ME
    Biotechnol Bioeng; 2007 Jul; 97(4):909-21. PubMed ID: 17154307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A tightly regulated and reversibly inducible siRNA expression system for conditional RNAi-mediated gene silencing in mammalian cells.
    Wu RH; Cheng TL; Lo SR; Hsu HC; Hung CF; Teng CF; Wu MP; Tsai WH; Chang WT
    J Gene Med; 2007 Jul; 9(7):620-34. PubMed ID: 17486668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cationic dendron-bearing lipids: investigating structure-activity relationships for small interfering RNA delivery.
    Zhang Y; Chen J; Xiao C; Li M; Tian H; Chen X
    Biomacromolecules; 2013 Dec; 14(12):4289-300. PubMed ID: 24144000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and evaluation of a novel nano-scale vector for siRNA.
    Jing GJ; Fu ZG; Dan B; Lin LR; Yang TC; Shi SL
    J Cell Biochem; 2010 Nov; 111(4):881-8. PubMed ID: 20665545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cationic cholesterol-modified gelatin as an in vitro siRNA delivery vehicle.
    Kadengodlu PA; Aigaki T; Abe H; Ito Y
    Mol Biosyst; 2013 May; 9(5):965-8. PubMed ID: 23303468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Receptor-targeted liposome-peptide nanocomplexes for siRNA delivery.
    Tagalakis AD; He L; Saraiva L; Gustafsson KT; Hart SL
    Biomaterials; 2011 Sep; 32(26):6302-15. PubMed ID: 21624650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polyene-based cationic lipids as visually traceable siRNA transfer reagents.
    Jubeli E; Raju L; Khalique NA; Bk N; Zegel C; Chen A; Lou HH; Øpstad CL; Zeeshan M; Sliwka HR; Partali V; Leopold PL; Pungente MD
    Eur J Pharm Biopharm; 2015 Jan; 89():280-9. PubMed ID: 25536113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of polyamidoamine dendrimer/alpha-cyclodextrin conjugate (generation 3, G3) as a novel carrier for small interfering RNA (siRNA).
    Tsutsumi T; Hirayama F; Uekama K; Arima H
    J Control Release; 2007 Jun; 119(3):349-59. PubMed ID: 17477999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liposomes and lipopolymeric carriers for gene delivery.
    Tros de Ilarduya C; García L; Düzgünes N
    J Microencapsul; 2010; 27(7):602-8. PubMed ID: 20923400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis.
    Khoury M; Louis-Plence P; Escriou V; Noel D; Largeau C; Cantos C; Scherman D; Jorgensen C; Apparailly F
    Arthritis Rheum; 2006 Jun; 54(6):1867-77. PubMed ID: 16729293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitumor activity of small interfering RNA/cationic liposome complex in mouse models of cancer.
    Yano J; Hirabayashi K; Nakagawa S; Yamaguchi T; Nogawa M; Kashimori I; Naito H; Kitagawa H; Ishiyama K; Ohgi T; Irimura T
    Clin Cancer Res; 2004 Nov; 10(22):7721-6. PubMed ID: 15570006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DOTAP functionalizing single-walled carbon nanotubes as non-viral vectors for efficient intracellular siRNA delivery.
    Li H; Hao Y; Wang N; Wang L; Jia S; Wang Y; Yang L; Zhang Y; Zhang Z
    Drug Deliv; 2016; 23(3):840-8. PubMed ID: 24892622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
    Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
    Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Choice of the adequate detection time for the accurate evaluation of the efficiency of siRNA-induced gene silencing.
    Choi I; Cho BR; Kim D; Miyagawa S; Kubo T; Kim JY; Park CG; Hwang WS; Lee JS; Ahn C
    J Biotechnol; 2005 Nov; 120(3):251-61. PubMed ID: 16095743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cationic lipids and polymers mediated vectors for delivery of siRNA.
    Zhang S; Zhao B; Jiang H; Wang B; Ma B
    J Control Release; 2007 Oct; 123(1):1-10. PubMed ID: 17716771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Detection of RNA interference in nasopharyngeal carcinoma cell lines using reporter genes].
    Yin ZH; Ren CP; Li F; Jiang WH; Yang XY; Feng XL; Yao KT
    Ai Zheng; 2005 Mar; 24(3):371-5. PubMed ID: 15757546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacious gene silencing in serum and significant apoptotic activity induction by survivin downregulation mediated by new cationic gemini tocopheryl lipids.
    Kumar K; Maiti B; Kondaiah P; Bhattacharya S
    Mol Pharm; 2015 Feb; 12(2):351-61. PubMed ID: 25438085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heavy chain ferritin siRNA delivered by cationic liposomes increases sensitivity of cancer cells to chemotherapeutic agents.
    Liu X; Madhankumar AB; Slagle-Webb B; Sheehan JM; Surguladze N; Connor JR
    Cancer Res; 2011 Mar; 71(6):2240-9. PubMed ID: 21385903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient silencing of EGFP reporter gene with siRNA delivered by asymmetrical N4,N9-diacyl spermines.
    Metwally AA; Reelfs O; Pourzand C; Blagbrough IS
    Mol Pharm; 2012 Jul; 9(7):1862-76. PubMed ID: 22129427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.